(Q30837072)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036458%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036458%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036458%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Claudio Ripellino

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036458%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

English

0 references

publication date

18 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036458%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Safety

9 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036458%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036458%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036458%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

1149-1154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036458%20AND%20SRC:MED&resulttype=core&format=json

Adverse effects of atypical antipsychotics : differential risk and clinical implications

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.943732

Arterial stiffness and stroke in hypertension: therapeutic implications for stroke prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.943732

Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.943732

Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.943732

Weight change and metabolic effects of asenapine in patients with schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.943732

The metabolic effects of antipsychotic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.943732

Evaluation of a behavioural weight management programme for patients with severe mental illness: 3 year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.943732

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.943732

Do guidelines for severe mental illness promote physical health and well-being?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.943732

10.1517/14740338.2014.943732

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25036458%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference